Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Boston MA, Providence RI, The Bronx NY, New York NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

Ovarian Tissue Freezing For Fertility Preservation

for
Malignancy, Fertility
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: Female

Age: 18 - 41

Code: NCT00902720

Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scarborough ME, Providence RI, Hartford CT, Quebec,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting
Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Fairfax VA, Chicago IL, San Antonio TX, Denver CO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07278336

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Providence RI, Teaneck NJ, Fairfax VA, Cincinnati OH,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06682988

Phase2, Recruiting

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer,
Location: Los Gatos CA
Sponsor: Bay Area Gynecology Oncology

Sex: All

Age: 18 - 70+

Code: NCT02349958

Phase2, Recruiting

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

for
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 2 - 18

Code: NCT00036712

Phase2, Recruiting

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

for
Fallopian Tube Cancer, Ovarian Cancer,
Location: Atlanta GA
Sponsor: Southeastern Gynecologic Oncology

Sex: Female

Age: 0+

Code: NCT00897039

Recruiting

Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Greenville SC
Sponsor: Oncolix, Inc.

Sex: Female

Age: 18+

Code: NCT02534922

Phase1, Recruiting

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

for
Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer,
Location: Houston TX
Sponsor: Critical Outcome Technologies Inc.

Sex: All

Age: 18+

Code: NCT02433626

Phase1, Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

for
Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor,
Location: The Bronx NY, New York NY, Hackensack NJ,
Sponsor: Xencor, Inc.

Sex: All

Age: 15+

Code: NCT06276491

Phase1, Recruiting

A Study Evaluating MM-310 in Patients With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma,
Location: Durham NC, Buffalo NY, Rochester MN, Scottsdale AZ,
Sponsor: Merrimack Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03076372

Phase1, Recruiting

A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

for
Colorectal Cancer, Triple Negative Breast Cancer,
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: OncXerna Theraputics, Inc.

Sex: All

Age: 18+

Code: NCT05453825

Phase2, Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

for
Ovarian Cancer
Location: The Bronx NY, New York NY, Fort Worth TX,
Sponsor: Xencor, Inc.

Sex: Female

Age: 18+

Code: NCT07593092

Phase1, Recruiting

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

for
Ovarian Cancer, Endometrial Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.

Sex: Female

Age: 18+

Code: NCT07755436

Phase1, Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07226427

Phase1, Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer,
Location: Montreal, Toronto, Pittsburgh PA, Grand Rapids MI,
Sponsor: MacroGenics

Sex: Female

Age: 18+

Code: NCT06730347

Phase2, Recruiting

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

for
Breast Cancer, Ovarian Cancer, Gynecologic Cancers,
Location: Stanford CA
Sponsor: Stanford University

Sex: Female

Age: 18+

Code: NCT01034033

Recruiting